Total Payments
$16,082
2024 Payments
$1,684
Companies
56
Transactions
485
Medicare Patients
2,644
Medicare Billing
$300,613
Payment Breakdown by Category
Food & Beverage$8,373 (52.1%)
Other$4,019 (25.0%)
Travel$1,600 (9.9%)
Research$1,125 (7.0%)
Consulting$950.00 (5.9%)
Education$15.02 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,373 | 467 | 52.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,825 | 6 | 23.8% |
| Travel and Lodging | $1,600 | 6 | 9.9% |
| Unspecified | $1,125 | 1 | 7.0% |
| Consulting Fee | $950.00 | 3 | 5.9% |
| Long term medical supply or device loan | $193.55 | 1 | 1.2% |
| Education | $15.02 | 1 | 0.1% |
Payments by Type
General
$14,957
484 transactions
Research
$1,125
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $5,698 | 27 | $0 (2019) |
| ABBVIE INC. | $2,602 | 74 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,331 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $1,017 | 71 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $710.41 | 53 | $0 (2024) |
| Shire North American Group Inc | $612.62 | 14 | $0 (2019) |
| Amgen Inc. | $543.75 | 36 | $0 (2024) |
| PFIZER INC. | $389.96 | 29 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $364.33 | 3 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $327.05 | 12 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,684 | 80 | ABBVIE INC. ($351.89) |
| 2023 | $1,061 | 74 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($234.35) |
| 2022 | $848.96 | 54 | Janssen Biotech, Inc. ($179.07) |
| 2021 | $380.21 | 4 | AbbVie Inc. ($365.53) |
| 2020 | $1,463 | 20 | AbbVie Inc. ($1,137) |
| 2019 | $1,421 | 100 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($254.96) |
| 2018 | $1,676 | 67 | Shire North American Group Inc ($540.61) |
| 2017 | $7,547 | 86 | Allergan Inc. ($5,674) |
All Payment Transactions
485 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PENTAX of America, Inc. | VIDEO COLONOSCOPE (Device) | Long term medical supply or device loan | In-kind items and services | $193.55 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Cleerly, Inc. | Cleerly Ischemia (Device), Cleerly Labs | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Immunology | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/30/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Endocrinology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Immunology | ||||||
| 10/02/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Obesity | ||||||
| 09/04/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Biosimilars | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 605 | 677 | $381,735 | $67,974 |
| 2022 | 13 | 737 | 832 | $434,107 | $83,676 |
| 2021 | 16 | 765 | 887 | $482,808 | $96,432 |
| 2020 | 10 | 537 | 633 | $263,094 | $52,531 |
Total Patients
2,644
Total Services
3,029
Medicare Billing
$300,613
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 65 | 65 | $94,733 | $15,024 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 146 | $53,322 | $14,514 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 99 | $24,773 | $7,285 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $22,000 | $4,813 | 21.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 42 | $18,857 | $4,544 | 24.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 64 | $15,156 | $4,274 | 28.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 72 | 96 | $12,347 | $4,144 | 33.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 38 | 38 | $45,427 | $3,756 | 8.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $13,794 | $2,765 | 20.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $13,836 | $2,411 | 17.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $30,800 | $2,305 | 7.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 15 | $36,691 | $2,138 | 5.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 70 | 70 | $102,020 | $15,585 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 146 | $53,322 | $15,114 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 154 | $38,535 | $10,362 | 26.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 59 | 61 | $72,922 | $6,436 | 8.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 53 | 54 | $24,245 | $6,342 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 66 | 66 | $23,958 | $5,746 | 24.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 58 | 78 | $18,472 | $4,712 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $20,350 | $4,681 | 23.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 22 | 22 | $14,329 | $4,323 | 30.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $36,399 | $3,472 | 9.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 15 | 15 | $12,290 | $3,070 | 25.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 57 | 72 | $9,260 | $2,428 | 26.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 31 | 31 | $8,005 | $1,405 | 17.6% |
About Dr. Anthony Delillo, MD
Dr. Anthony Delillo, MD is a Gastroenterology healthcare provider based in Emerson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356372536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Delillo, MD has received a total of $16,082 in payments from pharmaceutical and medical device companies, with $1,684 received in 2024. These payments were reported across 485 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($8,373).
As a Medicare-enrolled provider, Delillo has provided services to 2,644 Medicare beneficiaries, totaling 3,029 services with total Medicare billing of $300,613. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Emerson, NJ
- Active Since 07/05/2006
- Last Updated 07/12/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1356372536
Products in Payments
- LINZESS (Drug) $5,678
- STELARA (Biological) $902.45
- Entyvio (Biological) $855.83
- RINVOQ (Biological) $679.12
- XIFAXAN (Drug) $537.97
- XELJANZ (Drug) $265.06
- GATTEX (Drug) $250.00
- DUPIXENT (Biological) $243.47
- Humira (Biological) $236.13
- UCERIS (Drug) $234.47
- Sucraid (Drug) $229.80
- SKYRIZI (Biological) $201.95
- VIDEO COLONOSCOPE (Device) $193.55
- EVENITY (Biological) $192.09
- REMICADE (Biological) $184.22
- Enbrel (Biological) $171.70
- SIMPONI ARIA (Biological) $155.97
- TREMFYA (Drug) $139.11
- ENTYVIO (Biological) $138.47
- MOVIPREP (Drug) $128.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Emerson
Dr. Robert Pittman, Md, MD
Gastroenterology — Payments: $24,158
Gastroenterology $24,158
Dr. Crystal Broussard, Md, MD
Gastroenterology — Payments: $7,447
Gastroenterology $7,447
Dr. Robert Levine, Md, MD
Gastroenterology — Payments: $4,586
Gastroenterology $4,586
Dr. Eric Avezzano, Md, MD
Gastroenterology — Payments: $4,477
Gastroenterology $4,477
Alyse Bellomo, Md, MD
Gastroenterology — Payments: $4,067
Gastroenterology $4,067
Dr. Holly Cullen, M.d, M.D
Gastroenterology — Payments: $2,950
Gastroenterology $2,950